← FDA Drug Approvals (Drugs@FDA)

DEPAKOTE ER

NDA · New Drug Application · Sponsor: ABBVIE INC · Approved 2008-03-24

Drug application

FDA Application #

NDA022267

Application type

New Drug Application

Brand name

DEPAKOTE ER

Generic name

Divalproex Sodium

Active ingredients

DIVALPROEX SODIUM

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

ABBVIE INC

First approval

2008-03-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown